INVO Bioscience Stock Target Price and Analyst Consensus

INVO Stock  USD 1.52  0.30  16.48%   
The current analyst and expert consensus on INVO Bioscience is Hold, with no strong buy opinions. The current projected INVO Bioscience target price consensus is 20.00 with 1 analyst opinions. The most common way INVO Bioscience analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview INVO Bioscience executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on INVO Bioscience. We encourage you to use your own analysis of INVO Bioscience to validate this buy or sell advice. INVO Bioscience buy-or-sell recommendation module provides average expert sentiment on the projected INVO Bioscience target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on INVO Bioscience to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.
Lowest Forecast
18.2
Highest Forecast
22.2
Target Price
20
As of the 19th of April 2024, Gross Profit Margin is likely to grow to 0.54, while Gross Profit is likely to drop about 600.4 K. At this time, INVO Bioscience's Non Currrent Assets Other are very stable compared to the past year. As of the 19th of April 2024, Common Stock Shares Outstanding is likely to grow to about 1.7 M, though Retained Earnings are likely to grow to (54.9 M).
  
It's important to approach INVO Bioscience's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize INVO Bioscience price targets

INVO Bioscience's stock target price is an estimate of its future price, usually made by analysts. Using INVO Bioscience's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at INVO Bioscience's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if INVO Bioscience's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional INVO Bioscience Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of INVO Bioscience is a key component of INVO Bioscience valuation and have some predictive power on the future returns of a INVO Bioscience.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of INVO Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.081.5420.18
Details
Intrinsic
Valuation
LowRealHigh
0.306.0724.71
Details
Naive
Forecast
LowNextHigh
0.041.8520.49
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as INVO Bioscience. Your research has to be compared to or analyzed against INVO Bioscience's peers to derive any actionable benefits. When done correctly, INVO Bioscience's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in INVO Bioscience.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum Idea
Momentum
Invested over 70 shares
Manufacturing Idea
Manufacturing
Invested over 40 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Banking Idea
Banking
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested few shares
When determining whether INVO Bioscience offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of INVO Bioscience's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Invo Bioscience Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Invo Bioscience Stock:
Check out Macroaxis Advice on INVO Bioscience to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
To learn how to invest in INVO Stock, please use our How to Invest in INVO Bioscience guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for INVO Stock analysis

When running INVO Bioscience's price analysis, check to measure INVO Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INVO Bioscience is operating at the current time. Most of INVO Bioscience's value examination focuses on studying past and present price action to predict the probability of INVO Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INVO Bioscience's price. Additionally, you may evaluate how the addition of INVO Bioscience to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
The data published in INVO Bioscience's official financial statements usually reflect INVO Bioscience's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of INVO Bioscience. For example, before you start analyzing numbers published by INVO accountants, it's critical to develop an understanding of what INVO Bioscience's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of INVO Bioscience's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, INVO Bioscience's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in INVO Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of INVO Bioscience. Please utilize our Beneish M Score to check the likelihood of INVO Bioscience's management manipulating its earnings.